Fed. Circ. Affirms PTAB Ax Of Daiichi's Heart Drug Patents
The Federal Circuit upheld on Tuesday a Patent Trial and Appeal Board decision that invalidated as obvious a pair of Daiichi Sankyo's patents for use in the anti-blood clot drug Effient, which...To view the full article, register now.
Already a subscriber? Click here to view full article